Spark Therapeutics veteran brings over 25 years’ of leadership experience to drive translation of company’s bicistronic gene therapies into products.
– Camgenium and Cardiac Tech have developed an innovative solution to adverse events caused by current temporary pacing methods used in intensive care wards –
– Pace-Protect will be the first medical device using a Soft Silicon™ mesh network to be deployed in a clinical environment –
Why the “biology-first, modality-agnostic” era is eclipsing yesterday’s size-based dogma
Job type: 6 Month FTC project role, with potential to extend depending on project outcomes
Location: Oxford
Right to work: You must have the right to work in the UK
Application submission: CV and cover letter via our website www.omass.com/working-here/
We are seeking 1-2 highly capable and enthusiastic Senior Research Associate(s) to join the expanding Discovery & Engineering Unit at our South Cambridgeshire site (DEU III).
This will be an onsite and predominantly lab-based role. Working within a project team, you will independently execute antibody discovery experiments for client projects, ensuring high-quality outcomes and adherence to timelines.
We are seeking a highly capable and enthusiastic Senior Scientist to join the expanding Discovery & Engineering Unit at our South Cambridgeshire site (DEU III).
Teamwork is a key skill for this role - Senior Scientists are the highest-level lab-based role in FairJourney Biologics, providing lab-based leadership and collaborating with internal experts in antibody discovery & display technologies.
We are seeking a highly motivated and skilled scientist to join our Technology Unit, the research and development arm of FairJourney Biologics.
Successful candidates may be appointed at Scientist II or Senior Scientist level depending on experience, expertise, and leadership potential.
The Senior Commercialisation Manager is an important position in the Biopharma team of QMI, playing a significant role in initiating and maintaining an effective commercialisation strategy for opportunities principally from the Barts and London School of Medicine and Dentistry.
The post-holder will contribute to the delivery of a range of outputs including technology disclosures, protection of university IP, license and investment transactions, and new venture formation.
Anne Horgan, Partner at Cambridge Innovation Capital, talks about what makes her tick as an investor. She will chair the discussion on Nailing the Fundraise at BioBeat25. Co-organisers, Alisa Molotova, Start-up Mentor, and Miranda Weston-Smith, BioBeat founder chat with her about her role.
With almost 40m UK users, you can’t afford to ignore the power of LinkedIn to reach, connect and engage with other business users.
Join Dan Ince from social media agency BrandWorks Social for a thought-provoking talk on why you need to stand out more than ever on LinkedIn, and practical steps you can take to build visibility without it becoming overwhelming.